Doravirine/lamivudine/tenofovir (DOR/3TC/TDF), sold under the brand name Delstrigo, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS.[4][6] It contains doravirine, lamivudine, and tenofovir disoproxil.[7][6] It is taken by mouth.[4]
In the United States, it was approved by the Food and Drug Administration (FDA) for the treatment of HIV-1 infection in August 2018.[7][8][9]
References
- ↑ "PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION: DELSTRIGO" (PDF). Pdf.hres.ca. Retrieved 5 June 2022.
- ↑ "Drug and medical device highlights 2018: Helping you maintain and improve your health". Health Canada. 14 October 2020. Retrieved 17 April 2024.
- ↑ "Delstrigo 100 mg /300 mg /245 mg film-coated tablets - Summary of Product Characteristics (SmPC)". Medicines.org.uk. 8 July 2020. Retrieved 1 October 2020.
- 1 2 3 "Delstrigo- doravirine, lamivudine, and tenofovir disoproxil fumarate tablet, film coated". DailyMed. 10 October 2019. Retrieved 31 July 2020.
- ↑ "Delstrigo EPAR". European Medicines Agency (EMA). 21 September 2018. Retrieved 1 October 2020.
- 1 2 "Common Drug Review New Combination Product: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination (Delstrigo)". CADTH Common Drug Reviews. June 2019. PMID 31393687.
- 1 2 "FDA Approves Merck's Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and Pifeltro (doravirine), an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients" (Press release). Merck & Co. 30 August 2018.
- ↑ "Delstrigo approval letter" (PDF). Food and Drug Administration (FDA). 30 August 2018. Archived from the original (PDF) on 21 March 2019. Retrieved 10 September 2019.
- ↑ "Drug Approval Package: Pifeltro (doravirine)". U.S. Food and Drug Administration (FDA). 9 October 2018. Archived from the original on 1 October 2020. Retrieved 22 September 2020.
External links
- "doravirine lamuvidine tenofovir disoproxil fumarate". Canadian Agency for Drugs and Technologies in Health (CADTH). Archived from the original on 20 May 2021. Retrieved 11 September 2019.
